US midterms to shape drug pricing, Medicaid, and research funding

The upcoming US midterm elections could lead to significant shifts in health care policy, impacting drug pricing, Medicaid, and research funding. The outcome will determine whether current policies are maintained or reversed, affecting hospitals and pharmaceutical companies. The specific policy changes remain uncertain pending election results.